Prevalence of OSA and Diagnostic Accuracy of Type 3 Home Sleep Test in Difficult-to-treat Asthma

NAActive, not recruitingINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

February 7, 2024

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2025

Conditions
OSA
Interventions
DEVICE

home sleep test

Apnealink air

Trial Locations (1)

Unknown

Tidarat Somreusean, Bangkok

All Listed Sponsors
lead

Chulalongkorn University

OTHER

NCT06916858 - Prevalence of OSA and Diagnostic Accuracy of Type 3 Home Sleep Test in Difficult-to-treat Asthma | Biotech Hunter | Biotech Hunter